Muscovite nanoparticles mitigate neuropathic pain by modulating the inflammatory response and neuroglial activation in the spinal cord

Despite numerous efforts to overcome neuropathic pain, various pharmacological drugs often fail to meet the needs and have many side effects. Muscovite is an aluminosilicate mineral that has been reported to have an anti-inflammatory effect, but the efficacy of muscovite for neuropathic pain has not...

Full description

Bibliographic Details
Main Authors: Ju-Young Oh, Tae-Yeon Hwang, Jae-Hwan Jang, Ji-Yeun Park, Yeonhee Ryu, HyeJung Lee, Hi-Joon Park
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Neural Regeneration Research
Subjects:
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2020;volume=15;issue=11;spage=2162;epage=2168;aulast=Oh
_version_ 1818964231328890880
author Ju-Young Oh
Tae-Yeon Hwang
Jae-Hwan Jang
Ji-Yeun Park
Yeonhee Ryu
HyeJung Lee
Hi-Joon Park
author_facet Ju-Young Oh
Tae-Yeon Hwang
Jae-Hwan Jang
Ji-Yeun Park
Yeonhee Ryu
HyeJung Lee
Hi-Joon Park
author_sort Ju-Young Oh
collection DOAJ
description Despite numerous efforts to overcome neuropathic pain, various pharmacological drugs often fail to meet the needs and have many side effects. Muscovite is an aluminosilicate mineral that has been reported to have an anti-inflammatory effect, but the efficacy of muscovite for neuropathic pain has not been investigated. Here, we assessed whether muscovite nanoparticles can reduce the symptoms of pain by controlling the inflammatory process observed in neuropathic pain. The analgesic effects of muscovite nanoparticles were explored using partial sciatic nerve ligation model of neuropathic pain, in which one-third to one-half of the nerve trifurcation of the sciatic nerve was tightly tied to the dorsal side. Muscovite nanoparticles (4 mg/100 μL) was given intramuscularly to evaluate its effects on neuropathic pain (3 days per week for 4 weeks). The results showed that the muscovite nanoparticle injections significantly alleviated partial sciatic nerve ligation-induced mechanical and cold allodynia. In the spinal cord, the muscovite nanoparticle injections exhibited inhibitory effects on astrocyte and microglia activation and reduced the expression of pro-inflammatory cytokines, such as interleukin-1β, tumor necrosis factor-α, interleiukin-6 and monocyte chemoattractant protein-1, which were upregulated in the partial sciatic nerve ligation model. Moreover, the muscovite nanoparticle injections resulted in a decrease in activating transcription factor 3, a neuronal injury marker, in the sciatic nerve. These results suggest that the analgesic effects of muscovite nanoparticle on partial sciatic nerve ligation-induced neuropathic pain may result from inhibiting activation of astrocytes and microglia as well as pro-inflammatory cytokines. We propose that muscovite nanoparticle is a potential anti-nociceptive candidate for neuropathic pain. All experimental protocols in this study were approved by the Institutional Animal Ethics Committee (IACUC) at Dongguk University, South Korea (approval No. 2017-022-1) on September 28, 2017.
first_indexed 2024-12-20T12:57:49Z
format Article
id doaj.art-a61f808d6d3c4afea2d696de8c455ec7
institution Directory Open Access Journal
issn 1673-5374
language English
last_indexed 2024-12-20T12:57:49Z
publishDate 2020-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Neural Regeneration Research
spelling doaj.art-a61f808d6d3c4afea2d696de8c455ec72022-12-21T19:40:01ZengWolters Kluwer Medknow PublicationsNeural Regeneration Research1673-53742020-01-0115112162216810.4103/1673-5374.282260Muscovite nanoparticles mitigate neuropathic pain by modulating the inflammatory response and neuroglial activation in the spinal cordJu-Young OhTae-Yeon HwangJae-Hwan JangJi-Yeun ParkYeonhee RyuHyeJung LeeHi-Joon ParkDespite numerous efforts to overcome neuropathic pain, various pharmacological drugs often fail to meet the needs and have many side effects. Muscovite is an aluminosilicate mineral that has been reported to have an anti-inflammatory effect, but the efficacy of muscovite for neuropathic pain has not been investigated. Here, we assessed whether muscovite nanoparticles can reduce the symptoms of pain by controlling the inflammatory process observed in neuropathic pain. The analgesic effects of muscovite nanoparticles were explored using partial sciatic nerve ligation model of neuropathic pain, in which one-third to one-half of the nerve trifurcation of the sciatic nerve was tightly tied to the dorsal side. Muscovite nanoparticles (4 mg/100 μL) was given intramuscularly to evaluate its effects on neuropathic pain (3 days per week for 4 weeks). The results showed that the muscovite nanoparticle injections significantly alleviated partial sciatic nerve ligation-induced mechanical and cold allodynia. In the spinal cord, the muscovite nanoparticle injections exhibited inhibitory effects on astrocyte and microglia activation and reduced the expression of pro-inflammatory cytokines, such as interleukin-1β, tumor necrosis factor-α, interleiukin-6 and monocyte chemoattractant protein-1, which were upregulated in the partial sciatic nerve ligation model. Moreover, the muscovite nanoparticle injections resulted in a decrease in activating transcription factor 3, a neuronal injury marker, in the sciatic nerve. These results suggest that the analgesic effects of muscovite nanoparticle on partial sciatic nerve ligation-induced neuropathic pain may result from inhibiting activation of astrocytes and microglia as well as pro-inflammatory cytokines. We propose that muscovite nanoparticle is a potential anti-nociceptive candidate for neuropathic pain. All experimental protocols in this study were approved by the Institutional Animal Ethics Committee (IACUC) at Dongguk University, South Korea (approval No. 2017-022-1) on September 28, 2017.http://www.nrronline.org/article.asp?issn=1673-5374;year=2020;volume=15;issue=11;spage=2162;epage=2168;aulast=Ohastrocyte; microglia; muscovite; nanoparticle; neuropathic pain; partial sciatic nerve ligation; pharmacopuncture; pro-inflammatory cytokine; spinal cord
spellingShingle Ju-Young Oh
Tae-Yeon Hwang
Jae-Hwan Jang
Ji-Yeun Park
Yeonhee Ryu
HyeJung Lee
Hi-Joon Park
Muscovite nanoparticles mitigate neuropathic pain by modulating the inflammatory response and neuroglial activation in the spinal cord
Neural Regeneration Research
astrocyte; microglia; muscovite; nanoparticle; neuropathic pain; partial sciatic nerve ligation; pharmacopuncture; pro-inflammatory cytokine; spinal cord
title Muscovite nanoparticles mitigate neuropathic pain by modulating the inflammatory response and neuroglial activation in the spinal cord
title_full Muscovite nanoparticles mitigate neuropathic pain by modulating the inflammatory response and neuroglial activation in the spinal cord
title_fullStr Muscovite nanoparticles mitigate neuropathic pain by modulating the inflammatory response and neuroglial activation in the spinal cord
title_full_unstemmed Muscovite nanoparticles mitigate neuropathic pain by modulating the inflammatory response and neuroglial activation in the spinal cord
title_short Muscovite nanoparticles mitigate neuropathic pain by modulating the inflammatory response and neuroglial activation in the spinal cord
title_sort muscovite nanoparticles mitigate neuropathic pain by modulating the inflammatory response and neuroglial activation in the spinal cord
topic astrocyte; microglia; muscovite; nanoparticle; neuropathic pain; partial sciatic nerve ligation; pharmacopuncture; pro-inflammatory cytokine; spinal cord
url http://www.nrronline.org/article.asp?issn=1673-5374;year=2020;volume=15;issue=11;spage=2162;epage=2168;aulast=Oh
work_keys_str_mv AT juyoungoh muscovitenanoparticlesmitigateneuropathicpainbymodulatingtheinflammatoryresponseandneuroglialactivationinthespinalcord
AT taeyeonhwang muscovitenanoparticlesmitigateneuropathicpainbymodulatingtheinflammatoryresponseandneuroglialactivationinthespinalcord
AT jaehwanjang muscovitenanoparticlesmitigateneuropathicpainbymodulatingtheinflammatoryresponseandneuroglialactivationinthespinalcord
AT jiyeunpark muscovitenanoparticlesmitigateneuropathicpainbymodulatingtheinflammatoryresponseandneuroglialactivationinthespinalcord
AT yeonheeryu muscovitenanoparticlesmitigateneuropathicpainbymodulatingtheinflammatoryresponseandneuroglialactivationinthespinalcord
AT hyejunglee muscovitenanoparticlesmitigateneuropathicpainbymodulatingtheinflammatoryresponseandneuroglialactivationinthespinalcord
AT hijoonpark muscovitenanoparticlesmitigateneuropathicpainbymodulatingtheinflammatoryresponseandneuroglialactivationinthespinalcord